SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

BACKGROUND: Convalescent plasma therapy is a leading treatment for conferring temporary immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis. However, not all recovered patients develop adequate antibody titers for donation and the relationship between avidity and neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Benner, Sarah E, Patel, Eshan U, Laeyendecker, Oliver, Pekosz, Andrew, Littlefield, Kirsten, Eby, Yolanda, Fernandez, Reinaldo E, Miller, Jernelle, Kirby, Charles S, Keruly, Morgan, Klock, Ethan, Baker, Owen R, Schmidt, Haley A, Shrestha, Ruchee, Burgess, Imani, Bonny, Tania S, Clarke, William, Caturegli, Patrizio, Sullivan, David, Shoham, Shmuel, Quinn, Thomas C, Bloch, Evan M, Casadevall, Arturo, Tobian, Aaron A R, Redd, Andrew D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499592/
https://www.ncbi.nlm.nih.gov/pubmed/32910175
http://dx.doi.org/10.1093/infdis/jiaa581

Ejemplares similares

Ejemplares similares